Northwest Biotherapeutics, Inc. (NWBO)
Develops personalized cancer vaccines that train a patient's immune cells to attack their tumors.
$0.17-0.01%Healthcare
StockGlow Score
Leaning Bearish
BearishBullish
1 year ago-31.2%
The outlook
NWBO trades at $0.17, well below both its 50- and 200-day moving averages and near the bottom of its 52-week range. Analyst coverage is sparse, but the average price target implies roughly 480% upside from here. The overall sentiment leans bearish despite the wide target gap.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range14% of the way from its 52-week low to high
Price targetAvg target +482% vs current price
Market cap
$282.5M
52-wk high
$0.37
52-wk low
$0.14
50-day avg
$0.20
200-day avg
$0.23
Trailing P/E
—